Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

In recent decades, a new method of cellular immunotherapy was introduced based on engineering and empowering the immune effector cells. In this type of immunotherapy, the immune effector cells are equipped with chimeric antigen receptor (CAR) to specifically target cancer cells. In much of the trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Marofi, Faroogh, Rahman, Heshu Sulaiman, Thangavelu, Lakshmi, Dorofeev, Aleksey, Bayas-Morejón, Favian, Shirafkan, Naghmeh, Shomali, Navid, Chartrand, Max Stanley, Jarahian, Mostafa, Vahedi, Ghasem, Mohammed, Rebar N., Shahrokh, Somayeh, Akbari, Morteza, Khiavi, Farhad Motavalli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983395/
https://www.ncbi.nlm.nih.gov/pubmed/33752707
http://dx.doi.org/10.1186/s13287-021-02251-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983395/
https://www.ncbi.nlm.nih.gov/pubmed/33752707
http://dx.doi.org/10.1186/s13287-021-02251-7

Ejemplares similares